Christian Adam Smith - 26 Feb 2026 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
Chief Commercial Officer
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Issuer symbol
MMSI
Transactions as of
26 Feb 2026
Net transactions value
-$157,444
Form type
4
Filing time
02 Mar 2026, 14:00:00 UTC
Previous filing
11 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Smith Christian Adam Chief Commercial Officer 1600 W MERIT PARKWAY, SOUTH JORDAN /s/ Brian G. Lloyd, Attorney-in-Fact 02 Mar 2026 0002072266

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Award $0 +8,203 +75% $0.000000 19,181 26 Feb 2026 Direct F2
transaction MMSI Common Stock, No Par Value Award $0 +6,409 +33% $0.000000 25,590 26 Feb 2026 Direct F3
transaction MMSI Common Stock, No Par Value Award $0 +6,762 +26% $0.000000 32,352 26 Feb 2026 Direct F4
transaction MMSI Common Stock, No Par Value Tax liability $157,444 -2,018 -6.2% $78.02 30,334 26 Feb 2026 Direct F5
holding MMSI Common Stock, No Par Value 598 26 Feb 2026 By 401(k) Plan F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MMSI Non-qualified stock options (right to buy) 25,000 26 Feb 2026 Common Stock 25,000 $70.50 Direct F6
holding MMSI Non-qualified stock options (right to buy) 8,259 26 Feb 2026 Common Stock 8,259 $73.95 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents plan holdings as of 02/26/2026.
F2 Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.
F3 Represents a grant of RSUs. The RSUs vest in two equal installments on each of the second and the third anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.
F4 These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 03/31/2023.
F5 The Reporting Person surrendered 2,018 shares of common stock to the Issuer for payroll and income taxes. No shares were sold in the open market.
F6 Become exercisable in equal annual installments of 25% commencing on 10/4/2022.
F7 Become exercisable in equal annual installments of 25% commencing on 3/31/2024.